Tag archive for ‘Sinopharm Capital’

Israeli Oramed to raise $50 million from two Chinese investors

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP),  has signed a non-binding Letter of Intent (LoI) for an investment and license agreement in China with Sinopharm Capital Management Co. Ltd. and Hefei Life Science More...

Wordpress site Developed by Fixing WordPress Problems